Barclays
NUS icon

Barclays’s Nu Skin NUS Stock Holding History

Barclays’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,700
Closed -$146K – 6053
2020
Q1 		$146K Buy
6,700
+6,500
+3,250% +$196K ﹤0.01% 4517
2019
Q4 		$8K Sell
200
-1,900
-90% -$77.5K ﹤0.01% 6126
2019
Q3 		$89K Sell
2,100
-152,800
-99% -$6.41M ﹤0.01% 5562
2019
Q2 		$7.64M Buy
154,900
+153,600
+11,815% +$7.81M ﹤0.01% 1531
2019
Q1 		$62K Buy
+1,300
New +$78.8K ﹤0.01% 5718
2018
Q3 		– Sell
-300
Closed -$23K – 7307
2018
Q2 		$23K Hold
300
– – ﹤0.01% 6106
2018
Q1 		$22K Sell
300
-106,600
-100% -$7.57M ﹤0.01% 6391
2017
Q4 		$7.29M Sell
106,900
-1,800
-2% -$116K 0.01% 1382
2017
Q3 		$6.68M Buy
108,700
+3,900
+4% +$239K 0.01% 1317
2017
Q2 		$6.59M Buy
104,800
+103,100
+6,065% +$5.88M 0.01% 1265
2017
Q1 		$94K Sell
1,700
-10,500
-86% -$541K ﹤0.01% 4925
2016
Q4 		$583K Sell
12,200
-22,800
-65% -$1.28M ﹤0.01% 3231
2016
Q3 		$2.27M Buy
35,000
+27,600
+373% +$1.55M ﹤0.01% 1899
2016
Q2 		$342K Sell
7,400
-500
-6% -$20.1K ﹤0.01% 3519
2016
Q1 		$300K Sell
7,900
-28,100
-78% -$929K ﹤0.01% 3550
2015
Q4 		$1.33M Buy
36,000
+2,300
+7% +$84.8K ﹤0.01% 2352
2015
Q3 		$1.38M Sell
33,700
-6,300
-16% -$270K ﹤0.01% 2430
2015
Q2 		$1.88M Sell
40,000
-8,500
-18% -$460K ﹤0.01% 2265
2015
Q1 		$2.91M Sell
48,500
-16,500
-25% -$840K ﹤0.01% 1976
2014
Q4 		$2.8M Sell
65,000
-9,600
-13% -$424K ﹤0.01% 2227
2014
Q3 		$3.36M Sell
74,600
-20,800
-22% -$1.11M ﹤0.01% 2170
2014
Q2 		$6.96M Sell
95,400
-1,400
-1% -$110K 0.01% 1444
2014
Q1 		$7.94M Buy
96,800
+73,100
+308% +$6.42M 0.01% 1328
2013
Q4 		$3.27M Buy
23,700
+6,500
+38% +$765K ﹤0.01% 2176
2013
Q3 		$1.63M Sell
17,200
-4,500
-21% -$382K ﹤0.01% 2819
2013
Q2 		$1.33M Buy
+21,700
New +$1.2M ﹤0.01% 3021

Other funds holding NUS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Barclays's NUS Position: Q3 2026 in Review

Barclays increased its Nu Skin (NUS) stake by 238% in Q3 2026, buying an estimated $850K and bringing the position to 244,341 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2978.

Barclays first reported a position in NUS in Q2 2013 and has held it in 54 quarters since. The position peaked at $13.6M in Q2 2019. 74 funds tracked by Wall St. Rank hold NUS as of Q3 2026.

  • Barclays held 244,341 shares of Nu Skin worth $1.11M as of Q3 2026.
  • Barclays bought 172,119 Nu Skin shares in Q3 2026, an estimated $850K.
  • Nu Skin made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2978 holding.
  • Barclays first reported a position in Nu Skin in Q2 2013 and has held it in 54 quarters since.
  • Barclays's Nu Skin position peaked at $13.6M in Q2 2019.
  • 74 funds tracked by Wall St. Rank held Nu Skin as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.